KORU Medical Systems (NASDAQ:KRMD) Given New $4.00 Price Target at Canaccord Genuity Group

KORU Medical Systems (NASDAQ:KRMD) had its target price hoisted by Canaccord Genuity Group from $3.00 to $4.00 in a research note released on Thursday,Benzinga reports. The brokerage currently has a buy rating on the stock.

Several other research analysts have also recently issued reports on the stock. B. Riley assumed coverage on shares of KORU Medical Systems in a report on Thursday, July 25th. They set a “buy” rating and a $4.00 price target for the company. Piper Sandler increased their price target on shares of KORU Medical Systems from $3.00 to $3.50 and gave the stock an “overweight” rating in a report on Thursday.

KORU Medical Systems Trading Up 2.9 %

NASDAQ KRMD opened at $3.17 on Thursday. The stock has a market capitalization of $145.31 million, a P/E ratio of -12.68 and a beta of 0.41. KORU Medical Systems has a 52-week low of $1.98 and a 52-week high of $3.40. The firm has a 50-day moving average price of $2.67 and a 200 day moving average price of $2.48. The company has a quick ratio of 3.27, a current ratio of 2.99 and a debt-to-equity ratio of 0.01.

Institutional Inflows and Outflows

A number of hedge funds have recently added to or reduced their stakes in KRMD. Aaron Wealth Advisors LLC purchased a new position in KORU Medical Systems in the second quarter valued at about $28,000. Allspring Global Investments Holdings LLC acquired a new stake in shares of KORU Medical Systems in the second quarter valued at approximately $28,000. XTX Topco Ltd acquired a new stake in shares of KORU Medical Systems in the third quarter valued at approximately $34,000. Legato Capital Management LLC acquired a new stake in shares of KORU Medical Systems in the second quarter valued at approximately $35,000. Finally, Virtu Financial LLC acquired a new stake in shares of KORU Medical Systems in the first quarter valued at approximately $63,000. 58.60% of the stock is owned by hedge funds and other institutional investors.

About KORU Medical Systems

KORU Medical Systems, Inc develops and manufactures medical devices and supplies in the United States and internationally. It offers the freedom infusion systems to deliver life-saving therapies to patients with chronic illnesses, such as primary immunodeficiency diseases, chronic inflammatory demyelinating polyneuropathy, and paroxysmal nocturnal hemoglobinuria.